Comments on: Multicentric, Double-blind, Randomised Controled Trial of Hyperbaric-oxygen Therapy (HBOT) Versus Placebo for Treating Vaso-Occlusive Crisis (VOC) in Sickle Cell Disease (SCD) After 8 Years Old https://scdstudies.com/multicentric-double-blind-randomised-controled-trial-of-hyperbaric-oxygen-therapy-hbot-versus-placebo-for-treating-vaso-occlusive-crisis-voc-in-sickle-cell-disease-scd-after-8-years-old/?utm_source=rss&utm_medium=rss&utm_campaign=multicentric-double-blind-randomised-controled-trial-of-hyperbaric-oxygen-therapy-hbot-versus-placebo-for-treating-vaso-occlusive-crisis-voc-in-sickle-cell-disease-scd-after-8-years-old Wed, 19 Jun 2024 12:55:47 +0000 hourly 1 https://wordpress.org/?v=6.7.1